Cargando…
Correction to: Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161355/ https://www.ncbi.nlm.nih.gov/pubmed/30261847 http://dx.doi.org/10.1186/s12879-018-3370-8 |
_version_ | 1783358970690273280 |
---|---|
author | Cui, Shuhui Tobe, Ruoyan Gai Mo, Xiuting Liu, Xiaoyan Xu, Lingzhong Li, Shixue |
author_facet | Cui, Shuhui Tobe, Ruoyan Gai Mo, Xiuting Liu, Xiaoyan Xu, Lingzhong Li, Shixue |
author_sort | Cui, Shuhui |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6161355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61613552018-10-01 Correction to: Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option Cui, Shuhui Tobe, Ruoyan Gai Mo, Xiuting Liu, Xiaoyan Xu, Lingzhong Li, Shixue BMC Infect Dis Correction BioMed Central 2018-09-27 /pmc/articles/PMC6161355/ /pubmed/30261847 http://dx.doi.org/10.1186/s12879-018-3370-8 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Correction Cui, Shuhui Tobe, Ruoyan Gai Mo, Xiuting Liu, Xiaoyan Xu, Lingzhong Li, Shixue Correction to: Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option |
title | Correction to: Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option |
title_full | Correction to: Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option |
title_fullStr | Correction to: Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option |
title_full_unstemmed | Correction to: Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option |
title_short | Correction to: Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option |
title_sort | correction to: cost-effectiveness analysis of rotavirus vaccination in china: projected possibility of scale-up from the current domestic option |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161355/ https://www.ncbi.nlm.nih.gov/pubmed/30261847 http://dx.doi.org/10.1186/s12879-018-3370-8 |
work_keys_str_mv | AT cuishuhui correctiontocosteffectivenessanalysisofrotavirusvaccinationinchinaprojectedpossibilityofscaleupfromthecurrentdomesticoption AT toberuoyangai correctiontocosteffectivenessanalysisofrotavirusvaccinationinchinaprojectedpossibilityofscaleupfromthecurrentdomesticoption AT moxiuting correctiontocosteffectivenessanalysisofrotavirusvaccinationinchinaprojectedpossibilityofscaleupfromthecurrentdomesticoption AT liuxiaoyan correctiontocosteffectivenessanalysisofrotavirusvaccinationinchinaprojectedpossibilityofscaleupfromthecurrentdomesticoption AT xulingzhong correctiontocosteffectivenessanalysisofrotavirusvaccinationinchinaprojectedpossibilityofscaleupfromthecurrentdomesticoption AT lishixue correctiontocosteffectivenessanalysisofrotavirusvaccinationinchinaprojectedpossibilityofscaleupfromthecurrentdomesticoption |